{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:04:20Z","timestamp":1790946260127,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":813,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jtct.2020.11.024","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T14:05:29Z","timestamp":1609423529000},"page":"257.e1-257.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Does Mixed Chimerism After Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients With Fanconi Anemia Impact on Outcome?"],"prefix":"10.1016","volume":"27","author":[{"given":"Mouhab","family":"Ayas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khawar","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Al-Jefri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Al-Ahmari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Ghemlas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hawazen","family":"Al-Saedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awatif","family":"Al-Anazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadiya","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"El-Solh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Al-Seraihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2020.11.024_bib0001","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.hemonc.2017.05.014","article-title":"Hematopoietic cell transplantation in Fanconi anemia and dyskeratosis congenita: a minireview","volume":"10","author":"Ayas","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.jtct.2020.11.024_bib0002","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood-2015-04-639476","article-title":"Improving survival for Fanconi anemia patients","volume":"125","author":"Gluckman","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.024_bib0003","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3324\/haematol.2010.025619","article-title":"Inherited bone marrow failure syndromes","volume":"95","author":"Dokal","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2020.11.024_bib0004","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.beha.2014.10.002","article-title":"Fanconi anemia and the development of leukemia","volume":"27","author":"Alter","year":"2014","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jtct.2020.11.024_bib0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.hoc.2018.04.002","article-title":"Myelodysplastic syndrome, acute myeloid leukemia, and cancer surveillance in Fanconi anemia","volume":"32","author":"Savage","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jtct.2020.11.024_bib0006","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.critrevonc.2018.02.013","article-title":"Oral cancer in Fanconi anemia: review of 121 cases","volume":"125","author":"Furquim","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jtct.2020.11.024_bib0007","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrc.2017.116","article-title":"Fanconi anaemia and cancer: an intricate relationship","volume":"18","author":"Nalepa","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jtct.2020.11.024_bib0008","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.bmt.1702754","article-title":"Bone marrow transplantation from matched siblings in patients with fanconi anemia utilizing low-dose cyclophosphamide, thoracoabdominal radiation and antithymocyte globulin","volume":"27","author":"Ayas","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.024_bib0009","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2141.2006.06460.x","article-title":"Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: an update of the Cincinnati Children's experience","volume":"136","author":"Farzin","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2020.11.024_bib0010","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.bbmt.2011.08.015","article-title":"The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells","volume":"18","author":"Ayas","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.024_bib0011","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.bbmt.2014.06.016","article-title":"Factors affecting the outcome of related allogeneic hematopoietic cell transplantation in patients with Fanconi anemia","volume":"20","author":"Ayas","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.024_bib0012","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood-2006-07-036657","article-title":"Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia","volume":"109","author":"Wagner","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.024_bib0013","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbmt.2007.05.015","article-title":"Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival","volume":"13","author":"Gluckman","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.024_bib0014","doi-asserted-by":"crossref","first-page":"e27371","DOI":"10.1002\/pbc.27371","article-title":"Successful hematopoietic cell transplantation in Fanconi anemia patients with renal impairment using ultra-reduced doses of cyclophosphamide and fludarabine","volume":"65","author":"Ayas","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2020.11.024_bib0015","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.bbmt.2019.07.010","article-title":"Successful outcome in patients with fanconi anemia undergoing T cell-replete mismatched related donor hematopoietic cell transplantation using reduced-dose cyclophosphamide post-transplantation","volume":"25","author":"Ayas","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.024_bib0016","first-page":"143","article-title":"Relationship between mixed chimerism and rejection after bone marrow transplantation in thalassaemia","volume":"6","author":"Andreani","year":"2008","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jtct.2020.11.024_bib0017","first-page":"765","article-title":"Mixed donor chimerism in non-malignant haematological diseases after allogeneic bone marrow transplantation","volume":"22","author":"Shamshad","year":"2012","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.jtct.2020.11.024_bib0018","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/bmt.2017.231","article-title":"Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide","volume":"53","author":"Fouzia","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.024_bib0019","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1182\/blood-2015-12-684498","article-title":"The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis","volume":"127","author":"Hartz","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.024_bib0020","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1182\/blood.V126.23.2577.2577","article-title":"Nicolini mixed chimerism at three months after allogeneic hematopoietic stem cell transplantation is a significant predictor of disease relapse in high-risk acute myeloid leukemia patients in first complete remission","volume":"126","author":"Mauricette Michallet","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.024_bib0021","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.bbmt.2015.07.005","article-title":"Mixed T lymphocyte chimerism after allogeneic hematopoietic transplantation is predictive for relapse of acute myeloid leukemia and myelodysplastic syndromes","volume":"21","author":"Lee","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.024_bib0022","article-title":"Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation","author":"Srour","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2020.11.024_bib0023","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2014.7192","article-title":"Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype","volume":"312","author":"Hsieh","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2020.11.024_bib0024","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/bmt.2015.356","article-title":"Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants","volume":"51","author":"Masouridi-Levrat","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.024_bib0025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.bmt.1702151","article-title":"Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation","volume":"25","author":"Andreani","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.024_bib0026","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.bbmt.2014.04.001","article-title":"Mixed chimerism: good news or bad news?","volume":"20","author":"Parkman","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.024_bib0027","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/bmt.2008.89","article-title":"Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders","volume":"42","author":"Ozyurek","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.024_bib0028","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.blre.2004.06.003","article-title":"Kinetics of engraftment following allogeneic hematopoietic cell transplantation with reduced-intensity or nonmyeloablative conditioning","volume":"19","author":"Baron","year":"2005","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2020.11.024_bib0029","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.bbmt.2015.04.009","volume":"21","author":"Marsh","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.024_bib0030","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1182\/blood-2004-04-1506","article-title":"Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning","volume":"104","author":"Baron","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.024_bib0031","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.21873\/invivo.11703","article-title":"Influence of mixed chimerism on outcome in children with anaemia after haematopoietic stem cell transplantation","volume":"33","author":"Lejman","year":"2019","journal-title":"In Vivo"},{"key":"10.1016\/j.jtct.2020.11.024_bib0032","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3324\/haematol.2010.035576","article-title":"In mixed hematopoietic chimerism, the donor red cells win","volume":"96","author":"Hsieh","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2020.11.024_bib0033","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.trim.2017.09.004","article-title":"Chimerism in pediatric hematopoietic stem cell transplantation and its correlation with the clinical outcome","volume":"45","author":"Gabr","year":"2017","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.jtct.2020.11.024_bib0034","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bbmt.2013.02.015","article-title":"Chimerism patterns of long-term stable mixed chimeras posthematopoietic stem cell transplantation in patients with nonmalignant diseases: follow-up of long-term stable mixed chimerism patients","volume":"19","author":"Stikvoort","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.024_bib0035","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.bbmt.2017.08.038","article-title":"Relationship between mixed donor-recipient chimerism and disease recurrence after hematopoietic cell transplantation for sickle cell disease","volume":"23","author":"Abraham","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.024_bib0036","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1182\/blood.V82.7.2249.2249","article-title":"Bone marrow transplantation for Fanconi anemia using low-dose cyclophosphamide\/thoracoabdominal irradiation as conditioning regimen: chimerism study by the polymerase chain reaction","volume":"82","author":"Socie","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.024_bib0037","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.bmt.1701855","article-title":"Delayed engraftment and mixed chimerism after HLA-identical sibling donor BMT in Fanconi anaemia","volume":"24","author":"Mital","year":"1999","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636720300567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636720300567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:01:45Z","timestamp":1763002905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636720300567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2666636720300567"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2020.11.024","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Mixed Chimerism After Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients With Fanconi Anemia Impact on Outcome?","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2020.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}